What if you could visualise targeted proteins, drugs, lipids and metabolites from the same tissue sample without adding complex workflows or multiple imaging platforms?
Researchers working in spatial biology, translational medicine, and drug discovery are increasingly challenged to obtain more biological information while preserving precious samples. The solution lies in combining high-plex protein imaging with established MALDI mass spectrometry imaging (MSI) workflows.
AmberGen’s Miralys™ MALDI-IHC technology enables researchers to image over 100 targeted proteins alongside unlabelled small molecules, helping uncover disease mechanisms, accelerate biomarker discovery, and improve confidence in research decisions.
Discover how spatial multiomic imaging can deliver deeper insights from a single sample and a single workflow.
🔗 Read more: https://verulamscientific.com/ambergen/
📧 [email protected]
🌐 www.verulamscientific.com
